Moderators: Steven R. Gundry, M.D., David R. Clarke, M.D.

1. Aortic Valve Replacement, Age 17 through 50 Years: Effect of Valve Choice on Survival and Morbidity
Mark F. O'Brien, M.D. *, Ronald C. Elkins, M.D. *, Susan Harrocks, BN,RN *, Mary M. Lane, PhD *

Discussion opened by: Donald B. Doty, M.D.

2. Preoperative Prediction of the Risk of Pulmonary Complications After Esophagetomy for Cancer
Mark K. Ferguson, M.D. *, Amy E. Durkin, P.A. *

Discussion opened by: Richard I. Whyte, M.D.

3. Small Intestine Without Mucosa as a Growing Vascular Conduit - An Experimental Study
Om P. Tucker, M.D. *, Thomas Syburra, M.D. *, Monique Augstburger, RN *, Sandra Gebhard, M.D. *, Fred Bosman, M.D. *, Ludwig K. Von Segesser, M.D.*

Discussion opened by: Vadiyala M. Reddy, M.D.

Moderators: Donald B. Doty, M.D., Vaughn A. Starnes, M.D.

4. Clinical Experience with the St. Jude Aortic Connector System for Vein Grafts in Coronary Artery Bypass Surgery
Thierry P. Carrel, M.D. *, Friedrich S. Eckstein, M.D. *, Luis F. Bonilla, M.D. *, Lars Englberger, M.D. *, Franz F. Immer, M.D. *, Todd Berg, Jurg Schmidli, M.D. *

Discussion opened by: Robbin G. Cohen, M.D.

†5. Cyclosporine A and FK-506 Decrease Lung Ischemia Reperfusion Injury in Rats
Baiya Krishnadasan, M.D. *, Michael S. Mulligan, M.D., Babu Naidu, M.D.*, Edward D. Verrier, M.D., Angela Farr, B.A

Discussion opened by: Stuart W. Jamieson, M.D.

†6. Is Medical Therapy the Optimal Treatment Strategy for Acute Type B Dissections in the 21st Century?
Juan P. Umana, M.D. *, David T. Lai, M.D. *, R. Scott Mitchell, M.D., Filberto Rodriguez, M.D. *, Kathleen A. Moore, BS *, Robert C. Robbins, M.D., Philip E. Oyer, M.D., Michael D. Dake, M.D., Norman E. Shumway, M.D., Bruce A. Reitz, M.D.

Discussion opened by: Pat O. Daily, M.D.

7. Better Anticoagulation Control Improves Survival After Valve Replacement Eric G. Butchart*, Hui-Hua Li, M.D. *, Nicola Payne, BSc *, Keith Buchan, Gary L. Grunkemeier, PhD *

Discussion opened by: D. Craig Miller, M.D.

"What Should Be the Extent of Resection for Esophageal Cancer

Moderator: Douglas E. Wood, M.D.

Limited Resection: Richard Whyte, M.D.

Aggressive Resection: Thomas R. DeMeester, M.D.

A) Building an Esophageal Surgery Program: Politics and New Techniques
Thomas R. DeMeester, M.D.

B) Innovations in Aneurysm Management
Scott R. Mitchell, M.D.

C) Challenge the Experts in Congenital Heart Surgery
Marc DeLeval, M.D. & David R. Clarke, M.D.

Sponsored by: White Memorial Medical Center and Foundation -
Lyman A. Brewer, III Fund

Moderators: David M. Follette, M.D., Bradley A. Harlan, M.D.

8. Randomized Trial of Partial Vs. Complete Chordal Sparing Mitral Valve Replacement: Outcome (LV Mechanics) at One Year
Kwok L. Yun, M.D., Colleen F. Sintek, M.D., D. Craig Miller, M.D., Thomas A. Pfeffer, M.D., Gary S. Kochamba, M.D., Siavosh Khonsari, M.D., Michael R. Zile, M.D. *

Discussion opened by: Edward D. Verrier, M.D.

9. Impact of Prolonged Observation on Prognosis for Patients with Early Stage Non-Small Cell Lung Cancer
Renee L. Quarterman, M.D *, Mark B. Ratcliffe, M.D., Mark I. Block, M.D. *

Discussion opened by: John R. Benfield, M.D.

†10. Immunologic Sensitization in Recipients of Left Ventricular Assist Devices: Implications for Cardiac Allograft Rejection and Survival
Ranjit John, M.D. *, Silviu Itescu, M.D. *, Katherine Lietz, M.D., Yoshifumi Naka, M.D. *, Vivek Rao, M.D. *, Donna M. Mancini, M.D. *, Eric A. Rose, M.D. *, Craig R. Smith, M.D. *, Mehmet C. Oz, M.D. *, Niloo M. Edwards, M.D.*

Discussion opened by: Anees J. Razzouk, M.D.

11. Lack of Significant Survival Benefit of Mitral Repair in Patients with Ischemic Mitral Regurgitation
Alfredo Trento, M.D., Timothy A.. Denton, M.D. *, Robert M.. Kass, M.D. *, Carlos Blanche, M.D., Gregory P. Fontana, M.D., Wen Cheng, M.D.

Discussion opened by: Kent W. Jones, M.D.

Moderators: Steven W. Guyton, M.D., David N. Campbell, M.D.

12. Elimination of Cardiopulmonary Bypass Improves Immediate Survival in High Risk Coronary Artery Bypass Patients
Michal Savcenko, M.D.*, Mitchell J. Magee, M.D.*, Todd M. Dewey, M.D. *, James R. Edgerton, M.D. *, Syma L. Prince, R.N *, Michael J. Mack, M.D. *

Discussion opened by: Daniel J. Ullyot, M.D.

13. Neurodevelopmental Outcomes Following Biventricular Repair of Congenital Heart Defects
Joseph M. Forbess, M.D. *, Karen J. Visconti, PhD *, David Bellinger, PhD *, Robert J. Howe, CCP *, Richard A. Jonas, M.D. *

Discussion opened by: Leonard L. Bailey, M.D. †14. Aggressive Management of "Unacceptable" Lung Donors Results in Excellent One-Year Post-Transplant Survival
Michaela Straznicka, M.D. *, David M. Follette, M.D., Peter F. Roberts, M.D.*, Rebecca L. Menza, M.D. *, Wayne D. Badcock, M.D. *

Discussion opened by: Robert C. Robbins, M.D.

15. Combined Surgical and Endovascular Repair of Complex Thoracic Aortic Aneurysms: Options for Maximizing Both Techniques
David Spielvogel, M.D. *, Rafael Squitieri, M.D., Michael L. Marin, M.D. *, Larry L. Hollier, M.D. *, Randall B. Griepp, M.D.

Discussion opened by: R. Scott Mitchell, M.D.

EVENING - FREE

Workforce Requirements in a Rapidly Changing Environment

Richard Shemin, M.D.

Moderators: John A. Hawkins, M.D., Douglas E. Wood, M.D.

16. Elimination of Cardiotomy Suction Improves Reduction of Thrombin Generation and Inflammation in Patients Undergoing CABG with Heparin-Bonded Circuits
Gabriel S. Aldea, M.D. *, Louise O. Soltow, BS *, Wayne L. Chandler, M.D. *, Yong T. Shin, M.D. *, William E. Curtis, M.D. *, Edward D. Verrier, M.D.

Discussion opened by: Andrew S. Wechsler, M.D.

17. EN Bloc Resection of NSCLC Invading the Thoracic Inlet and the Intervertebral Foramen
Elie Fadel, M.D. *, Gilles Missenard, M.D. *, Alain Chapelier, M.D. *, Christophe Lancelin, M.D. *, Phillipe Dartevelle, M.D. *

Discussion opened by: Douglas E. Wood, M.D.

18. Improved Survival with Total Autologous Repair of Hypoplastic Left Heart Syndrome
Vaughn A. Starnes, M.D., Hector Arroyo, Jr., M.D. *, John J.. Nigro, M.D. *, Mark L. Barr, M.D. *, Winfield J. Wells, M.D.

Discussion opened by: Steven R. Gundry, M.D.

19. Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Aids Surgical Staging of Non-Small Cell Lung Cancer (NSCLC)
Hubert Vesselle, Ph.D. M.D. *, Jeffrey M.. Pugsley, B.A. *, Eric Vallieres, M.D., Douglas E. Wood, M.D.

Discussion opened by: John D. Mitchell, M.D.

†20. Novel Cardioprotective Effects of Tetrahydrobiopterin Following Ischemia-Reperfusion
Subodh Verma, M.D., PhD, Todd J. Anderson, M.D., Richard D. Weisel, M.D., Andrew Maitland, M.D., Neil C. Pomroy, M. SC., Shu-Hong Li, M. SC., Paul W. M. Fedak, M.D., Vivek Rao, M.D, PhD, Ren-Ke Li, M.D., PhD., Donald A. G. Mickle, M.D.

Discussion opened by: David M. Follette, M.D.

21. Failed Aortic Root Allografts Placed in Childhood: Surgical Options and Results
Max B. Mitchell, M.D. *, David N. Campbell, M.D., Debbie A. Bishop, BS *, Todd A. MacKenzie, PhD *, David R. Clarke, M.D.

Discussion opened by: John A. Hawkins, M.D.

Moderators: David R. Clarke, M.D., Robert J. McKenna, M.D.

22. Improved Long-term Survival in Esophogeal Cancer Following the Novel Strategy of Induction Chemotherapy Prior to Concurrent Chemoradiation and Surgery
Stephen G. Swisher, M.D.*, Jaffer A. Ajani, M.D. *, Ritsuko Komaki, M.D.*, Garrett L. Walsh, M.D.*, Jonathon Nesbitt, M.D.*, Faye Martin, M.D. *, Sandeep Lahoti, M.D.*, William R. Smythe, M.D.*, Ara A. Vaporciyan, M.D.*, Joe B. Putnam, M.D.*, Jack A. Roth, M.D.*

Discussion opened by: Walter J. Erman, M.D.

†23. Performance of an Unstented Xenograft Mitral Valve Substitute
Tomasz A. Timek, M.D. *, David T M. Lai, M.D. *, Fredrick A. Tibayan, M.D. *, David Liang, M.D., PhD *, George T. Daughters, M.S. *, Paul Dagum, M.D.,PhD *, Neil B. Ingels, PhD *, D. Craig Miller, M.D.

Discussion opened by: Vaughn A. Starnes, M.D.

†24. Results of Video-Assisted Trans-Cervical Thymectomy in 120 Consecutive Patients
Marc de Perrot, M.D.*, Vera Bril, M.D.*, Karen McRae, M.D.*, Shaf Keshavjee, M.D.*

Discussion opened by: Michael S. Mulligan, M.D.

Protagonist: Robert Sade, M.D.

Antagonist: Thomas J. Fogarty, M.D.

Moderator: Richard Sanderson, M.D.